Interobserver reproducibility of the interpretation of I-123 FP-CIT single-photon emission computed tomography

Nuclear Medicine Communications

Volumn 31, Issue 8, 2010, Pages 717-725

  Tondeur, Marianne C ^a   Hambye, Anne Sophie ^b   Dethy, Sophie ^b   Ham, Hamphrey R ^c  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b Centre Hospitalier Universitaire de Tivoli   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

agreement; I 123 ioflupane single photon emission computed tomography; interobserver; Parkinson; reproducibility

Indexed keywords

COCAINE DERIVATIVE; IODINE 123; IOFLUPANE; IOFLUPANE I 123; UNCLASSIFIED DRUG; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; ISOTOPE LABELING; MALE; OBSERVER VARIATION; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; MIDDLE AGED; PHYSICIAN; PROCEDURES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OBSERVER VARIATION; PHYSICIANS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 77954225658     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833b7ea4     Document Type: Article

References (25)

1. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in Parkinsonism: a prospective study. Can J Neurol Sci 1991; 18:275-278.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
3. Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AGM, et al. 123-I FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62:133-140.
4. Booij J, Speelman JD, Horstink MWIM, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with 123-I FP-CIT SPECT in differentiating patients with presynaptic Parkinsonism from those with other forms of Parkinsonism. Eur J Nucl Med 2001; 28:266-272.
5. Catafau AM, Tolosa E. Impact of dopamine transporter SPECT Using 123-I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 2004; 19:1175-1182.
6. Winogrodzka A, Bergmans P, Booij J, van Royen EA, Janssen AGM, Wolters ECh. 123I-FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease. J Neural Transm 2001; 108:1011-1019.
7. Lokkergaard A, Werdelin LM, Friberg L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med 2002; 29:1623-1629.
8. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord 2003; 18:1415-1423.
9. Benamer HTS, Patterson J, Grosset DG. Accurate differentiation of Parkinsonism and essential tremor using visual assessment of I123-FP-CIT SPECT imaging: The 123I-FP CIT Study Group. Mov Disord 2000; 15:503-510.
10. Booij J, Habraken JBA, Bergmans P, Tissingh G, Winogrodzka A, Wolters Ech, et al. Imaging of dopamine transporters with Iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 1998; 39:1879-1884.
11. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005; 46:1109-1118.
12. Tsuchida T, Ballinger JR, Vines D, Kim YJ, Utsunomiya K, Lang AE, et al. Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients. Ann Nucl Med 2004; 18:609-616.
13. Tondeur M, Sand A, Ham H. Inter-observer reproducibility in the interpretation of Tc-99m labelled white blood cell scintigraphic images. Nucl Med Commun 2008; 29:1093-1099.
14. De Sadeleer C, Tondeur M, Melis K, Van Espen MB, Verelst J, Ham H, Piepsz A. A multicenter trial on interobserver reproducibility in reporting on 99mTc-DMSA planar scintigraphy: a belgian survey. J Nucl Med 2000; 41:23-26.
15. Tondeur M, Sand A, Ham H. Interobserver reproducibility in the interpretation of captopril renograms from patients suspected of having renovascular hypertension. Clin Nucl Med 2004; 29:479-484.
16. Tondeur M, Sand A, Ham H. Interobserver reproducibility in the interpretation of bone scans from patients suspected of having reflex sympathetic dystrophy. Clin Nucl Med 2005; 30:4-10.
17. Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. http://www.eanm.org
18. Tondeur M, De Palma D, Roca I, Piepsz A, Ham H. Inter-observer reproducibility in reporting on renal drainage in children with hydronephrosis: a large collaborative study. Eur J Nucl Med Mol Imaging 2008; 35:644-654.
19. Tondeur M, De Palma D, Roca I, Piepsz A, Ham H. Inter-observer reproducibility in reporting on renal cortical scintigraphy in children A large collaborative study. Nucl Med Commun 2009; 30:258-262.
20. Tolosa E, Borght TV, Moreno E; DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Accuracy of DaTSCAN (123I-ioflupane) SPECT in diagnosis of patients with clinically uncertain Parkinsonism: 2-year follow-up of an open-label study. Mov Disord 2007; 22:2346-2351.
21. Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W, Vander Borght T. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of Parkinsonism. Eur J Nucl Med Mol Imaging 2008; 35:1367-1376.
22. Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 2000; 27:867-869.
23. Acton PD, Newberg A, Plössl K, David Mozley P. Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using 99mTc-TRODAT-1 and SPECT. Phys Med Biol 2006; 51:575-585.
24. Cosgriff PS, Fleming JS, Jarritt PH, Skrypniuk J, Bailey D, Whalley D, et al. UK audit on glomerular filtration rate measurement in 2001. Nucl Med Comm 2008; 29:511-520.
25. Sadik M, Suurkula M, Höglund P, Järund A, Edenbrandt L. Quality of planar whole-body bone scan interpretations-a nationwide survey. Eur J Nucl Med Mol Imaging 2008; 35:1464-1472.